2022 Q1 Form 10-Q Financial Statement

#000143774922012337 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $4.523M $2.857M
YoY Change 58.31% 2.33%
Cost Of Revenue $3.286M $2.089M
YoY Change 57.3% -5.48%
Gross Profit $1.237M $768.0K
YoY Change 61.07% 31.96%
Gross Profit Margin 27.35% 26.88%
Selling, General & Admin $2.665M $1.417M
YoY Change 88.07% -3.01%
% of Gross Profit 215.44% 184.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $247.0K $68.00K
YoY Change 263.24% 161.54%
% of Gross Profit 19.97% 8.85%
Operating Expenses $2.665M $1.417M
YoY Change 88.07% -3.01%
Operating Profit -$1.428M -$649.0K
YoY Change 120.03% -26.17%
Interest Expense $231.0K $60.00K
YoY Change 285.0% 57.89%
% of Operating Profit
Other Income/Expense, Net $0.00 -$7.000K
YoY Change -100.0% -153.85%
Pretax Income -$1.657M -$715.0K
YoY Change 131.75% -19.39%
Income Tax $7.000K $4.000K
% Of Pretax Income
Net Earnings -$1.664M -$719.0K
YoY Change 131.43% -19.3%
Net Earnings / Revenue -36.79% -25.17%
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share -$21.41K -$11.38K
COMMON SHARES
Basic Shares Outstanding 77.72M 63.16M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.86M $3.577M
YoY Change 231.45% -27.06%
Cash & Equivalents $11.90M $3.577M
Short-Term Investments
Other Short-Term Assets $477.0K $266.0K
YoY Change 79.32% 57.4%
Inventory $2.907M $1.774M
Prepaid Expenses
Receivables $3.216M $1.824M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.46M $7.441M
YoY Change 148.03% -20.76%
LONG-TERM ASSETS
Property, Plant & Equipment $222.0K $294.0K
YoY Change -24.49% 92.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.000K $33.00K
YoY Change -75.76% 0.0%
Total Long-Term Assets $568.0K $772.0K
YoY Change -26.42% 5.32%
TOTAL ASSETS
Total Short-Term Assets $18.46M $7.441M
Total Long-Term Assets $568.0K $772.0K
Total Assets $19.02M $8.213M
YoY Change 131.63% -18.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.735M $1.123M
YoY Change 54.5% -9.0%
Accrued Expenses $1.526M $888.0K
YoY Change 71.85% 38.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.893M $809.0K
YoY Change 257.6%
Total Short-Term Liabilities $6.273M $3.045M
YoY Change 106.01% 54.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $304.0K
YoY Change -100.0% -77.41%
Other Long-Term Liabilities $238.0K $369.0K
YoY Change -35.5% -40.48%
Total Long-Term Liabilities $238.0K $673.0K
YoY Change -64.64% -65.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.273M $3.045M
Total Long-Term Liabilities $238.0K $673.0K
Total Liabilities $6.510M $3.718M
YoY Change 75.09% -5.54%
SHAREHOLDERS EQUITY
Retained Earnings -$73.46M -$70.70M
YoY Change 3.9% 4.16%
Common Stock $85.56M $74.78M
YoY Change 14.42% 1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.51M $4.495M
YoY Change
Total Liabilities & Shareholders Equity $19.02M $8.213M
YoY Change 131.63% -18.87%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.664M -$719.0K
YoY Change 131.43% -19.3%
Depreciation, Depletion And Amortization $247.0K $68.00K
YoY Change 263.24% 161.54%
Cash From Operating Activities -$2.341M -$1.043M
YoY Change 124.45% 1.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $14.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$14.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.506M $9.000K
YoY Change 105522.22% -250.0%
NET CHANGE
Cash From Operating Activities -$2.341M -$1.043M
Cash From Investing Activities $0.00 -$14.00K
Cash From Financing Activities $9.506M $9.000K
Net Change In Cash $7.166M -$1.048M
YoY Change -783.78% 1.16%
FREE CASH FLOW
Cash From Operating Activities -$2.341M -$1.043M
Capital Expenditures $0.00 $14.00K
Free Cash Flow -$2.341M -$1.057M
YoY Change 121.48% 2.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Assets
Assets
10246000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1735000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1239000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1526000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1544000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
9000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8000 USD
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
55000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6273000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3585000 USD
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1778000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
237000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
266000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
6510000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71796000 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92252188
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
114000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
373000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
627000 USD
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92252188
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92252188
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67840941
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67840941
CY2022Q1 jsda Adjustments To Additional Paid In Capital Common Stock And Warrant Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantIssuedIssuanceCosts
848000 USD
CY2022Q1 jsda Number Of Wholly Owned Operating Subsidiaries
NumberOfWhollyOwnedOperatingSubsidiaries
4 USD
CY2021Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 USD
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11856000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4667000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3216000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2662000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
2907000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1923000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
477000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
358000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
18456000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9610000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
222000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
338000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
365000 USD
CY2018Q1 us-gaap Share Price
SharePrice
0.36
CY2018Q2 us-gaap Share Price
SharePrice
0.30
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33000 USD
CY2022Q1 us-gaap Assets
Assets
19024000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
5629000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
85561000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
76017000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
412000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
396000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73460000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
12513000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4617000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19024000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10246000 USD
CY2022Q1 us-gaap Revenues
Revenues
4523000 USD
CY2021Q1 us-gaap Revenues
Revenues
2857000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3286000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2089000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
1237000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
768000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1143000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
661000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1522000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
756000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2665000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
1417000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1428000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-649000 USD
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
2000 USD
CY2021Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
231000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
60000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1657000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-715000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1664000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-719000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77721719
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63156112
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1664000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-719000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
16000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
8000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1648000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-711000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4379000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
53000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
763000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-719000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4495000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4617000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
268000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2124000 USD
CY2022Q1 jsda Common Stock And Warrants Issued During Period Value
CommonStockAndWarrantsIssuedDuringPeriodValue
7152000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1664000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
16000 USD
CY2021Q1 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
2000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11900000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4700000 USD
CY2022Q1 jsda Working Capital Deficit
WorkingCapitalDeficit
12200000 USD
CY2021Q4 jsda Working Capital Deficit
WorkingCapitalDeficit
6000000.0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2300000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000000.0 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
247000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68000 USD
CY2022Q1 jsda Slotting Fees And Promotional Allowances
SlottingFeesAndPromotionalAllowances
308000 USD
CY2021Q1 jsda Slotting Fees And Promotional Allowances
SlottingFeesAndPromotionalAllowances
350000 USD
CY2022Q1 jsda Maximum Discount For Customers Payment Made Within15 Days
MaximumDiscountForCustomersPaymentMadeWithin15Days
0.02 pure
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
114000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-719000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
12513000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1664000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
268000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
53000 USD
CY2022Q1 jsda Accounts Receivable Credit Loss Expense Reversal Less Writeoffs
AccountsReceivableCreditLossExpenseReversalLessWriteoffs
-3000 USD
CY2021Q1 jsda Accounts Receivable Credit Loss Expense Reversal Less Writeoffs
AccountsReceivableCreditLossExpenseReversalLessWriteoffs
-22000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
545000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
229000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
982000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-86000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
119000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
72000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
496000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-260000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-66000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
51000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1000 USD
CY2022Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1000 USD
CY2021Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
2000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2341000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1043000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000 USD
CY2022Q1 jsda Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
7152000 USD
CY2021Q1 jsda Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9506000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7166000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1048000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4667000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4614000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11856000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3577000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
47000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000 USD
CY2022Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2124000 USD
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
763000 USD
CY2022Q1 jsda Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
0 USD
CY2021Q1 jsda Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
0 USD
CY2022Q1 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
0 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
42000 USD
CY2022Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
4000000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2051000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1361000 USD
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
856000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
562000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
2907000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1923000 USD
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
12000 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
8000 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
43000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
43000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
40000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
92000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
126000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
130000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
22000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
370000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
348000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3405511
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.25
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
625648
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.37
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
74074
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.45
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3957085
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.27
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3085511
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.22
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3708291
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.26
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3589783
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
998450
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.36
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.34
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4563233
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2880121
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.39
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4070942
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.38
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
268000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
681000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
662000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2700 USD
CY2022Q1 us-gaap Revenues
Revenues
4523000 USD
CY2021Q1 us-gaap Revenues
Revenues
2857000 USD

Files In Submission

Name View Source Status
0001437749-22-012337-index-headers.html Edgar Link pending
0001437749-22-012337-index.html Edgar Link pending
0001437749-22-012337.txt Edgar Link pending
0001437749-22-012337-xbrl.zip Edgar Link pending
ex_374730.htm Edgar Link pending
ex_374731.htm Edgar Link pending
ex_374732.htm Edgar Link pending
ex_374733.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jsda-20220331.xsd Edgar Link pending
jsda-20220331_cal.xml Edgar Link unprocessable
jsda-20220331_def.xml Edgar Link unprocessable
jsda-20220331_lab.xml Edgar Link unprocessable
jsda-20220331_pre.xml Edgar Link unprocessable
jsda20220331_10q.htm Edgar Link pending
jsda20220331_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending